Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

Oral Presentation: OP21: ABX464 is safe and efficacious in a proof of concept study in ulcerative colitis patientsScientific Programme
Year: 2019
Authors: Jean-Marc Steens
Oral Presentation: OP23: CKD-506, a novel histone deacetylase (HDAC) 6 inhibitor, ameliorates colitis in various animal modelsScientific Programme
Year: 2019
Authors: Jieun Shin
Oral Presentation: OP24: Effectiveness and safety of ustekinumab 90 mg every four weeks in Crohn's diseaseScientific Programme
Year: 2019
Authors: Mathurin Fumery
Oral Presentation: OP25: Targeting endoscopic outcomes through combined pharmacokinetic and pharmacodynamic monitoring of infliximab therapy in patients with Crohn’s diseaseScientific Programme
Year: 2019
Authors: Erwin Dreesen
Oral Presentation: OP26: Long-term safety of vedolizumab in ulcerative colitis and Crohn’s disease: Final results from the GEMINI LTS studyScientific Programme
Year: 2019
Authors: Remo Panaccione
Oral Presentation: OP29: ST2+/IL-33 responsive cells promote tumorigenesis in colitis-associated colorectal cancerScientific Programme
Year: 2019
Authors: Loris Riccardo Lopetuso
Oral Presentation: OP30: Serum proteomic profiling predicts and diagnoses pouchitis in ulcerative colitis patients undergoing ileal pouch-anal anastomosisScientific Programme
Year: 2019
Authors: Kathleen Machiels
Oral Presentation: OP34: VARSITY: A Double-Blind, Double-Dummy, Randomised, Controlled Trial of Vedolizumab Versus Adalimumab in Patients With Active Ulcerative ColitisScientific Programme
Year: 2019
Authors: Stefan Schreiber
Oral Presentation: OP37: Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFIScientific Programme
Year: 2019
Authors: William J. Sandborn
Oral Presentation: OP38: Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with moderately-to-severely active ulcerative colitisScientific Programme
Year: 2019
Authors: Geert D'Haens
Outcomes from the ECCO Fellowship 2018: Monocyte-derived macrophages as crucial players in the resolution of inflammation and tissue repair in Inflammatory Bowel DiseaseScientific Programme
Year: 2019
Authors: Sales Ibiza
Outcomes from the ECCO Fellowship 2018: Role of TNF-inducible gene-6 (TSG-6) in fistulising Crohn's DiseaseScientific Programme
Year: 2019
Authors: Sudharshan Elangovan
Outcomes from the ECCO Pioneer Award 2017: Faecal transplantation using a novel conditioning method for donor and recipient in mild to moderate treatment refractory colitis in Inflammatory Bowel DiseaseScientific Programme
Year: 2019
Authors: Arie Levine
Outcomes of first admission for acute severe ulcerative colitis over a decade in EnglandJCC Podcast
Year: 2019
Authors: Dominic King et al.

Dominic King discusses his paper reporting the outcomes of >10,000 admissions in this challenging patient group, including a trend towards lower emergency colectomy rates along with a rapid increase in anti-TNF usage.

Outcomes of the ECCO-IOIBD Fellowship 2018 Deciphering the gut-specific B cell response in Inflammatory Bowel DiseaseScientific Programme
Year: 2019
Authors: Mathieu Uzzan
Patient perspectives of guidelines - why should patients be involved1st Guideline Methodology and GRADE Workshop
Year: 2019
Authors: Ciara Drohan
Postoperative Management of CDTalking Heads
Year: 2019
Authors: Marc Ferrante, Uri Kopylov, Paulo Kotze
Postoperative medical prevention after ileocecal resection for CD8th S-ECCO IBD Masterclass
Year: 2019
Authors: Pierre Michetti
Postoperative morbidity after iterative ileocolonic resection for Crohn’s Disease: should we be worried?JCC Podcast
Year: 2019
Authors: Jeremie H. Lefevre et al.

Jérémie Lefevre discusses the work of the GETAID surgical group examining post-operative outcomes for a large series of patients undergoing repeat ileocolonic resection and reports some reassuring findings.

Pouch excision and definitive stoma is much better!8th S-ECCO IBD Masterclass
Year: 2019
Authors: Pär Myrelid